Compare Cigna Corp (CI) vs HubSpot Inc (HUBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs HubSpot Inc — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while HubSpot Inc trades at $220.51 (market cap $10.77B). The key difference: Cigna Corp is far larger — about 6.8× HubSpot Inc's market cap, and Cigna Corp pays a 2.24% dividend while HubSpot Inc pays none. Which is the better fit depends on your goals.
| CI | HUBS | |
|---|---|---|
Market Cap | $73.56B | $10.77B |
Sector | Health | Technology |
52-Week High | $311.00 | $522.97 |
52-Week Low | $244.41 | $170.39 |
Enterprise Value | $98.27B | $9.67B |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
HubSpot (HUBS) trades at $210.35, up 3.91% today, but remains in a bearish technical trend with strong selling pressure on moving averages. The company shows solid revenue growth with Q2 2026 earnings beating estimates at $3.26 EPS, though recent guidance cuts and a securities fraud investigation have created significant volatility. Fundamentals reveal strong gross margins of 83.25% but modest net income margins of 4.26%, with valuation metrics indicating premium pricing at P/E 74.89 and P/S 3.22.
The outlook is mixed with 76.59% analyst buy ratings and a $233.93 consensus target suggesting 11% upside, but near-term risks from customer growth slowdown and legal challenges weigh on sentiment. Long-term AI transformation strategy offers potential, but execution risks and competitive pressures require careful monitoring for investors considering entry at current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →
